Skip to content

Research at St Andrews

Vitamin D deficiency in Malawian adults with pulmonary tuberculosis: risk factors and treatment outcomes

Research output: Contribution to journalArticle

DOI

Open Access permissions

Open

Author(s)

Derek James Sloan, H. C. Mwandumba, M. Kamdolozi, D. Shani, B. Chisale, J. Dutton, S. H. Khoo, T. J. Allain, G. R. Davies

School/Research organisations

Abstract

SETTING: Vitamin D deficiency is common in African adults with tuberculosis (TB), and may be exacerbated by the metabolic effects of anti-tuberculosis drugs and antiretroviral therapy (ART). It is unclear whether vitamin D deficiency influences response to antituberculosis treatment.

OBJECTIVES : To describe risk factors for baseline vitamin D deficiency in Malawian adults with pulmonary TB, assess the relationship between serum 25-hydroxy vitamin D (25[OH]D) concentration and treatment response, and evaluate whether the administration of anti-tuberculosis drugs and ART is deleterious to vitamin D status during treatment.

DESIGN: A prospective longitudinal cohort study.

RESULTS : The median baseline 25(OH)D concentration of the 169 patients (58% human immunodeficiency virus [HIV] infected) recruited was 57 nmol/l; 47 (28%) had vitamin D deficiency (<50 nmol/l). Baseline 25(OH)D concentrations were lower during the cold season (P < 0.001), with food insecurity (P = 0.034) or in patients who consumed alcohol (P  = 0.019). No relationship between vitamin D status and anti-tuberculosis treatment response was found. 25(OH)D concentrations increased during anti-tuberculosis treatment, irrespective of HIV status or use of ART.

CONCLUSIONS : Vitamin D deficiency is common among TB patients in Malawi, but this does not influence treatment response. Adverse metabolic effects of drug treatment may be compensated by the positive impact of clinical recovery preventing exacerbation of vitamin D deficiency during anti-tuberculosis treatment.

Close

Details

Original languageEnglish
Pages (from-to)904-911
Number of pages8
JournalInternational Journal of Tuberculosis and Lung Disease
Volume19
Issue number8
DOIs
Publication statusPublished - 1 Aug 2015

    Research areas

  • HIV, Antiretroviral therapy, Relapse, Seasonality, Treatment failure

Discover related content
Find related publications, people, projects and more using interactive charts.

View graph of relations

Related by author

  1. PrimeStore MTM and OMNIgene sputum for the preservation of sputum for Xpert MTB/RIF testing in Nigeria

    Bimba, J. S., Lawson, L., Kontogianni, K., Edwards, T., Ekpenyong, B. E., Dodd, J., Adams, E. R., Sloan, D. J., Cresswell, J., Dominguez, J. & Cuevas, L. E., 4 Dec 2019, In : Journal of Clinical Medicine. 8, 12, 9 p., 2146.

    Research output: Contribution to journalArticle

  2. Defining the roles of Data Manager and Epidemiologist in emergency medical teams

    Bartolucci, A., Jafar, A. JN., Sloan, D. J. & Whitworth, J., 16 Oct 2019, In : Prehospital and Disaster Medicine. First View, 7 p.

    Research output: Contribution to journalArticle

  3. Genetic diversity of Mycobacterium tuberculosis clinical isolates in Blantyre, Malawi

    Ndhlovu, V., Kiran, A., Sloan, D., Mandala, W., Kontogianni, K., Kamdolozi, M., Caws, M. & Davies, G., Oct 2019, In : Heliyon. 5, 10, 5 p., e02638.

    Research output: Contribution to journalArticle

  4. A tuberculosis molecular bacterial load assay (TB-MBLA)

    Sabiiti, W., Mtafya, B. A., Alferes De Lima, D., Dombay, E., Baron, V. O., Azam, K., Orascova, K., Sloan, D. J. & Gillespie, S. H., 6 Sep 2019, (Accepted/In press) In : Journal of Visualized Experiments.

    Research output: Contribution to journalArticle

  5. Protocol for the development of the STrengthening the Reporting of Pharmacogenetic Studies (STROPS) guideline: checklist of items for reporting pharmacogenetic studies

    Richardson, M., Kirkham, J. J., Dwan, K. M., Sloan, D. J., Davies, G. & Jorgensen, A., 11 Jul 2019, In : BMJ Open. 9, 7, 5 p., e030212.

    Research output: Contribution to journalArticle

Related by journal

  1. NAT2 variants and toxicity related to anti-tuberculosis agents: a systematic review and meta-analysis

    Richardson, M., Kirkham, J., Dwan, K., Sloan, D. J., Davies, G. & Jorgensen, A. L., 1 Mar 2019, In : International Journal of Tuberculosis and Lung Disease. 23, 3, p. 293-305 13 p.

    Research output: Contribution to journalArticle

  2. Equitable tuberculosis care in the North West of England: analysis of tuberculosis cohort review data

    MacPherson, P., Squire, S. B., Cleary, P., Davies, S., Wake, C., Dee, K., Walker, J., Farrow, S., McMaster, P., Woodhead, M., Sloan, D. J. & North West TB Audit Steering Committee, 1 Jun 2016, In : International Journal of Tuberculosis and Lung Disease. 20, 6, p. 778-785 8 p.

    Research output: Contribution to journalArticle

  3. Optimising molecular diagnostic capacity for effective control of tuberculosis in high-burden settings

    Sabiiti, W., Mtafya, B., Kuchaka, D., Azam, K., Viegas, S., Mdolo, A., Farmer, E., Khonga, M., Evangelopoulos, D., Honeyborne, I., Rachow, A., Heinrich, N., Ntinginya, N. E., Bhatt, N., Davies, G. R., Jani, I. V., McHugh, T. D., Kibiki, G., Hoelscher, M., Gillespie, S. H. & 1 others, PANBIOME (Pan-African Biomarker Expansion Programme) consortium, 1 Aug 2016, In : International Journal of Tuberculosis and Lung Disease. 20, 8, p. 1004-1009

    Research output: Contribution to journalArticle

  4. Tuberculosis in the time of Ebola: Obstacles and opportunities

    Sloan, D. J. & O'Dempsey, T. J., 1 Nov 2015, In : International Journal of Tuberculosis and Lung Disease. 19, 11, p. 1269 1 p.

    Research output: Contribution to journalEditorial

Related by journal

  1. International Journal of Tuberculosis and Lung Disease (Journal)

    Stephen Henry Gillespie (Editor)
    2011

    Activity: Publication peer-review and editorial work typesEditor of research journal

ID: 241920764

Top